{"id":"clindamycin-benzoyl-peroxide-gel","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation/erythema"},{"rate":null,"effect":"Dryness"},{"rate":null,"effect":"Peeling"},{"rate":null,"effect":"Contact dermatitis"}]},"_chembl":{"chemblId":"CHEMBL1200370","moleculeType":"Small molecule","molecularWeight":"242.23"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effectively eliminating Propionibacterium acnes. Benzoyl peroxide is an oxidizing agent that generates reactive oxygen species to kill bacteria and also helps normalize keratinization and reduce sebaceous gland activity. Together, they provide synergistic antibacterial and anti-inflammatory effects for acne treatment.","oneSentence":"Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides additional antimicrobial and keratolytic effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:43:28.968Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"}]},"trialDetails":[{"nctId":"NCT07421804","phase":"NA","title":"Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT07205107","phase":"","title":"Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2025-10-02","conditions":"Acne Vulgaris","enrollment":200},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT06336629","phase":"PHASE4","title":"A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2023-11-15","conditions":"Acne Vulgaris","enrollment":10},{"nctId":"NCT06673641","phase":"PHASE1","title":"A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-05-13","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT01044264","phase":"NA","title":"Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":602},{"nctId":"NCT03849885","phase":"PHASE4","title":"Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Colorado Joint Replacement","startDate":"2019-02-02","conditions":"Degenerative Osteoarthritis","enrollment":496},{"nctId":"NCT00671749","phase":"PHASE4","title":"Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":100},{"nctId":"NCT02515305","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-07","conditions":"Acne","enrollment":890},{"nctId":"NCT01796665","phase":"PHASE3","title":"A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-02","conditions":"Acne","enrollment":1180},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT00441415","phase":"PHASE3","title":"Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":272},{"nctId":"NCT02005666","phase":"PHASE3","title":"To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel","status":"COMPLETED","sponsor":"Zydus Lifesciences Limited","startDate":"2013-11","conditions":"Acne Vulgaris","enrollment":850},{"nctId":"NCT03122457","phase":"PHASE2","title":"Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2017-01-01","conditions":"Actinic Keratosis","enrollment":22},{"nctId":"NCT02616614","phase":"PHASE3","title":"Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-05","conditions":"Acne Vulgaris","enrollment":862},{"nctId":"NCT03257202","phase":"PHASE2","title":"Topical Treatment and Prevalence of P. Acnes","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-09-11","conditions":"Surgical Site Infection","enrollment":12},{"nctId":"NCT03402893","phase":"PHASE4","title":"The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2017-07-28","conditions":"Acne Vulgaris, Post Inflammatory Hyperpigmentation","enrollment":21},{"nctId":"NCT02731105","phase":"PHASE4","title":"Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2015-02","conditions":"Acne Vulgaris","enrollment":22},{"nctId":"NCT02557399","phase":"PHASE4","title":"DUAC® Early Onset Efficacy Study in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-07","conditions":"Acne Vulgaris","enrollment":350},{"nctId":"NCT02578043","phase":"PHASE1","title":"A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":844},{"nctId":"NCT01445301","phase":"PHASE3","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09-27","conditions":"Acne Vulgaris","enrollment":800},{"nctId":"NCT02058628","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-21","conditions":"Acne Vulgaris","enrollment":222},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT01428466","phase":"PHASE1","title":"Japanese Phase 1 Study of GSK2585823","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-18","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT02465632","phase":"PHASE3","title":"To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":1100},{"nctId":"NCT01132443","phase":"PHASE1","title":"W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-05-06","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT00964366","phase":"PHASE4","title":"Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":53},{"nctId":"NCT00160394","phase":"PHASE4","title":"Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2004-12","conditions":"Acne Vulgaris","enrollment":130},{"nctId":"NCT00841776","phase":"PHASE4","title":"Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2007-08","conditions":"Acne","enrollment":54},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01769235","phase":"PHASE1","title":"Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-11","conditions":"Acne Vulgaris","enrollment":1215},{"nctId":"NCT02595034","phase":"PHASE1","title":"A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT01015638","phase":"PHASE4","title":"Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT00713609","phase":"PHASE2","title":"Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-06","conditions":"Acne Vulgaris","enrollment":591},{"nctId":"NCT01915732","phase":"PHASE3","title":"A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":1018},{"nctId":"NCT01016977","phase":"PHASE4","title":"A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT00887484","phase":"PHASE4","title":"A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00964223","phase":"PHASE4","title":"A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT00776919","phase":"PHASE3","title":"Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":1315},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT01400932","phase":"PHASE3","title":"Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":360},{"nctId":"NCT01769664","phase":"PHASE1","title":"A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-09","conditions":"Acne Vulgaris","enrollment":650},{"nctId":"NCT01788384","phase":"PHASE3","title":"Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris","status":"COMPLETED","sponsor":"Watson Laboratories, Inc.","startDate":"2012-07","conditions":"Acne Vulgaris","enrollment":708},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT01472900","phase":"NA","title":"2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2010-10","conditions":"Acne Vulgaris","enrollment":25},{"nctId":"NCT00807014","phase":"PHASE4","title":"Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Acne Vulgaris","enrollment":169},{"nctId":"NCT01206348","phase":"PHASE4","title":"Combination Treatment for Moderate to Severe Acne","status":"COMPLETED","sponsor":"Medicis Global Service Corporation","startDate":"2010-09","conditions":"Acne","enrollment":97},{"nctId":"NCT01448733","phase":"PHASE4","title":"Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01422785","phase":"PHASE4","title":"A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT01052246","phase":"NA","title":"Pulsed Dye Laser Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Laserklinik Karlsruhe","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00377000","phase":"PHASE4","title":"A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-11","conditions":"Acne Vulgaris","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":6,"reaction":"ACNE"},{"count":5,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"APPLICATION SITE ERYTHEMA"},{"count":2,"reaction":"APPLICATION SITE DRYNESS"},{"count":2,"reaction":"APPLICATION SITE EXFOLIATION"},{"count":2,"reaction":"APPLICATION SITE PAIN"},{"count":2,"reaction":"APPLICATION SITE PRURITUS"},{"count":2,"reaction":"APPLICATION SITE RASH"},{"count":2,"reaction":"DRUG EFFECT DECREASED"},{"count":1,"reaction":"APNOEA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Clindamcyin Phosphate","BPO","Duac® Gel"],"phase":"marketed","status":"active","brandName":"Clindamycin/benzoyl peroxide gel","genericName":"Clindamycin/benzoyl peroxide gel","companyName":"Actavis Inc.","companyId":"actavis-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides additional antimicrobial and keratolytic effects. Used for Acne vulgaris.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}